SkyOak Wealth’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
SkyOak Wealth's ARKG Position: Q3 2026 in Review
SkyOak Wealth held its ARK Genomic Revolution ETF (ARKG) position steady in Q3 2026 at 5,068 shares worth $275K. The position accounts for 0.04% of the portfolio, ranked #190.
SkyOak Wealth first reported a position in ARKG in Q4 2019 and has held it in 20 quarters since. The position peaked at $1.5M in Q1 2021. 99 funds tracked by Wall St. Rank hold ARKG as of Q3 2026.
- SkyOak Wealth held 5,068 shares of ARK Genomic Revolution ETF worth $275K as of Q3 2026.
- SkyOak Wealth left its ARK Genomic Revolution ETF share count unchanged in Q3 2026.
- ARK Genomic Revolution ETF made up 0.04% of SkyOak Wealth's portfolio in Q3 2026, its #190 holding.
- SkyOak Wealth first reported a position in ARK Genomic Revolution ETF in Q4 2019 and has held it in 20 quarters since.
- SkyOak Wealth's ARK Genomic Revolution ETF position peaked at $1.5M in Q1 2021.
- 99 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2026.
Based on SkyOak Wealth's 13F filing for Q3 2026, filed 28 Oct 2026.